Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -127.05%-6.51M | 703K | -102.65%-767K | -385.46%-5.21M | 67.23%-1.24M | 237.29%24.06M | 0 | 405.32%28.9M | -188.24%-1.07M | -67.21%-3.77M |
| Net profit before non-cash adjustment | -471.47%-79.74M | ---15.16M | -533.21%-61.09M | -21.22%-2.84M | 67.14%-645K | 87.60%-13.95M | --0 | 83.15%-9.65M | -179.36%-2.34M | -149.50%-1.96M |
| Total adjustment of non-cash items | 1,262.67%58.23M | --50.06M | 239.90%7.66M | -72.36%301K | -77.12%213K | -93.01%4.27M | --0 | -82.17%2.25M | -33.03%1.09M | -16.13%931K |
| -Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | -37.26%1.15M | ---- | ---- | ---- | ---- |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | ---- | -31.56%30.58M | ---- | ---- | ---- | ---- |
| -Disposal profit | ---- | ---- | ---- | ---- | ---- | -103.34%-366.77K | ---- | ---- | ---- | ---- |
| -Other non-cash items | ---- | ---- | ---- | ---- | ---- | -1,333.82%-44.88M | ---- | ---- | ---- | ---- |
| Changes in working capital | -55.54%15M | ---34.19M | 45.10%52.67M | -1,583.89%-2.67M | 70.66%-803K | -0.49%33.74M | --0 | 3.29%36.3M | 105.36%180K | 62.66%-2.74M |
| -Change in receivables | 130.78%5.33M | 74.41%-17.01M | -51.09%21.89M | -211.46%-3.22M | 141.67%3.67M | -253.13%-17.32M | -210.48%-66.48M | 14.64%44.76M | 132.48%2.89M | -41.01%1.52M |
| -Change in inventory | 1,466.93%5.21M | --5.6M | 71.58%-811K | -81.93%443K | -200.00%-21K | -107.41%-381K | --0 | -235.78%-2.85M | -45.03%2.45M | 101.25%21K |
| -Change in payables | 171.11%9.96M | ---18.09M | 762.60%30.44M | 116.24%505K | 54.11%-2.89M | -150.54%-14.01M | --0 | 21.86%-4.59M | -287.18%-3.11M | 23.35%-6.31M |
| -Changes in other current assets | -108.40%-5.5M | -107.05%-4.69M | 213.43%1.15M | 80.56%-399K | -176.80%-1.56M | 183.95%65.45M | 179.81%66.48M | -723.58%-1.01M | -248.98%-2.05M | --2.03M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | -86.98%103K | -46K | 98.70%-55K | -97.77%112K | 3,166.67%92K | 117.52%791K | 0 | -14.44%-4.24M | 891.35%5.03M | -100.19%-3K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -125.77%-6.41M | --657K | -103.33%-822K | -228.71%-5.1M | 69.70%-1.14M | 212.75%24.85M | --0 | 287.27%24.66M | 582.76%3.96M | -489.38%-3.77M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 790.00%138K | --76K | 542.86%62K | --0 | --0 | 97.50%-20K | --0 | -250.00%-14K | ---3K | 25.00%-3K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net investment property transactions | --0 | --0 | ---- | ---- | ---- | --2.01M | --0 | ---- | ---- | ---- |
| Net investment product transactions | -88.66%612K | --0 | 120.36%295K | -69.61%317K | --0 | -6.72%5.4M | --0 | -125.00%-1.45M | 193.71%1.04M | 58,130.00%5.8M |
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | ---- | ---- | -5.15%2.16K | ---- | ---- | ---- | ---- |
| Interest received (cash flow from investment activities) | -58.65%55K | --2K | -11.54%23K | -81.25%9K | -64.41%21K | -72.99%133K | --0 | -46.94%26K | 71.43%48K | -26.25%59K |
| Net changes in other investments | ---- | ---- | ---- | ---- | ---- | 246.28%5.74M | ---- | ---- | ---- | ---- |
| Investing cash flow | -89.29%805K | --78K | -33.10%380K | -70.04%326K | -99.64%21K | 46.30%7.52M | --0 | -90.27%568K | 200.28%1.09M | 8,777.27%5.86M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 91.06%-2.69M | ---1.67M | 96.53%-781K | 99.68%-10K | 94.91%-225K | -1,196.91%-30.09M | --0 | -721.25%-22.51M | -606.50%-3.15M | -648.39%-4.42M |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Increase or decrease of lease financing | -113.44%-146K | ---25K | -102.05%-25K | 85.45%-16K | -220.00%-80K | 323.52%1.09M | --0 | 515.31%1.22M | -358.33%-110K | -31.58%-25K |
| Interest paid (cash flow from financing activities) | 75.63%-629K | ---337K | 88.03%-112K | 89.67%-102K | 88.15%-78K | 35.99%-2.58M | --0 | 50.40%-936K | 0.10%-987K | 17.02%-658K |
| Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | -119.56%-89.83K | ---- | ---- | ---- | ---- |
| Financing cash flow | 89.03%-3.47M | ---2.04M | 95.87%-918K | 96.99%-128K | 92.50%-383K | -2,300.88%-31.58M | --0 | -1,640.47%-22.23M | -191.36%-4.25M | -263.93%-5.11M |
| Net cash flow | ||||||||||
| Beginning cash position | -24.83%16.2M | -62.22%8.44M | -49.32%9.8M | -20.70%14.7M | -24.83%16.2M | -54.73%21.55M | -31.09%22.34M | -49.52%19.34M | -53.97%18.54M | -48.97%21.55M |
| Current changes in cash | -1,257.73%-9.07M | ---1.3M | -145.30%-1.36M | -712.38%-4.9M | 50.15%-1.51M | 104.30%783K | --0 | 150.99%3M | 140.75%800K | -52.71%-3.02M |
| End cash Position | -68.04%7.14M | -68.04%7.14M | -62.22%8.44M | -49.32%9.8M | -20.70%14.7M | -24.00%22.34M | -24.00%22.34M | -31.09%22.34M | -49.52%19.34M | -53.97%18.54M |
| Free cash flow | -125.79%-6.41M | --657K | -103.33%-822K | -228.81%-5.1M | 69.72%-1.14M | 208.72%24.83M | --0 | 287.10%24.65M | 582.24%3.96M | -486.18%-3.78M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.